Mar 17, 2021 14:11 UTC

The US has been criticized for purchasing 200 million more COVID-19 vaccines for its own citizens and pushing poorer countries and vulnerable populations to the back of the queue, while experts estimate that low-income countries will experience wide access after 2022.

ME

Tags